Eagle Pharmaceuticals Operating Cash Flow 2011-2026 | EGRX

Annual Operating Cash Flow Eagle Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
50.7 M	28.2 M	49.5 M	56 M	52.4 M	58.9 M	53.2 M	-9.72 M	-13.8 M	-5.88 M	-15.5 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
58.9 M	-15.5 M	27.6 M

Quarterly Operating Cash Flow Eagle Pharmaceuticals

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-33.5 M	-	13.1 M	26.4 M	-16.6 M	-	20.1 M	19.1 M	10.5 M	-	29.7 M	24.1 M	3.16 M	-	59.2 M	48.6 M	26.2 M	-	14.3 M	10.6 M	4.92 M	-	33 M	25.1 M	-12.4 M	-	13.7 M	484 K	3.11 M	-	7.08 M	13.7 M	25.8 M	-7.88 M	-13.9 M	-6.74 M	-2.07 M	23 K	-5.56 M	-2.83 M	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
59.2 M	-33.5 M	10.3 M

Operating Cash Flow of other stocks in the Drug manufacturers industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
AcelRx Pharmaceuticals ACRX	-12.7 M	-	7.5 %	$ 6.35 M	USA
Agile Therapeutics AGRX	-9.58 M	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	-14.3 M	-	-	$ 142 M	USA
Adamis Pharmaceuticals Corporation ADMP	-25.9 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	-99.2 M	-	-	$ 754 M	USA
Avadel Pharmaceuticals plc AVDL	-46.9 M	-	-	$ 2.06 B	France
Canopy Growth Corporation CGC	-166 M	$ 1.17	1.74 %	$ 126 M	Canada
China Pharma Holdings CPHI	-466 K	$ 0.61	-1.46 %	$ 10.7 M	China
Cumberland Pharmaceuticals CPIX	-612 K	$ 3.92	2.08 %	$ 55.1 M	USA
Catalent CTLT	268 M	-	-	$ 11.5 B	USA
Evoke Pharma EVOK	-4.98 M	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	-462 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	-43.1 M	-	2.45 %	$ 38.1 M	Canada
Harrow Health HROW	3.84 M	$ 52.78	2.39 %	$ 1.72 B	USA
DURECT Corporation DRRX	-34.4 M	-	-	$ 50.1 M	USA
Emergent BioSolutions EBS	-206 M	$ 10.96	-	$ 561 M	USA
Endo International plc ENDP	435 M	-	-	$ 28.9 M	Irlanda
Athenex ATNX	-131 M	-	-23.39 %	$ 1.76 M	USA
Evolus EOLS	-18 M	$ 4.3	-0.69 %	$ 267 M	USA
Lannett Company LCI	-7.12 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	-28.6 M	$ 1.42	1.43 %	$ 402 M	Canada
Jupiter Wellness JUPW	-7.57 M	-	-	$ 33.6 M	USA
Pacira BioSciences PCRX	189 M	$ 23.41	1.3 %	$ 1.08 B	USA
Bausch Health Companies BHC	1.03 B	$ 6.02	-	$ 2.2 B	Canada
Sundial Growers SNDL	-155 M	$ 1.55	4.03 %	$ 3.37 M	Canada
Neoleukin Therapeutics NLTX	-51.4 M	-	-	$ 193 M	Canada
Tilray TLRY	7.91 M	$ 7.92	4.9 %	$ 4.89 B	Canada
Organogenesis Holdings ORGO	14.2 M	$ 4.03	2.81 %	$ 531 M	USA
PetIQ PETQ	61.9 M	-	1.64 %	$ 400 M	USA
Perrigo Company plc PRGO	363 M	$ 14.61	-	$ 2.01 B	USA
Aurora Cannabis ACB	-211 M	$ 3.79	3.84 %	$ 86.3 M	Canada
ProPhase Labs PRPH	28.6 M	-	-	$ 5.07 M	USA
Radius Health RDUS	-22.4 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	-1 M	-	-4.76 %	$ 65.3 M	USA
Rockwell Medical RMTI	-9.41 M	$ 0.94	2.02 %	$ 21.9 M	USA
Relmada Therapeutics RLMD	-51.7 M	$ 4.26	5.71 %	$ 128 M	USA
OptiNose OPTN	-20.5 M	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	49.6 M	$ 11.94	-0.83 %	$ 848 M	USA
PLx Pharma PLXP	-32.1 M	-	-27.8 %	$ 2.56 M	USA
Sonoma Pharmaceuticals SNOA	-88 K	$ 2.84	-	$ 3.52 M	USA
Solid Biosciences SLDB	-100 M	$ 6.18	5.28 %	$ 252 M	USA
SCYNEXIS SCYX	60.2 M	$ 0.79	2.18 %	$ 37.8 M	USA
Tricida TCDA	-140 M	-	-	$ 3.25 M	USA
Veru VERU	-21.7 M	$ 2.61	5.24 %	$ 352 M	USA
TherapeuticsMD TXMD	-159 M	$ 2.25	-1.32 %	$ 23.5 M	USA
cbdMD YCBD	-353 K	$ 0.93	1.85 %	$ 4.01 M	USA
Zynerba Pharmaceuticals ZYNE	-23 M	-	-	$ 55.5 M	USA
Viatris VTRS	3 B	$ 16.07	0.72 %	$ 19.5 B	USA